METTL3 and ovarian carcinoma: Furthermore, ASO-mediated inhibition of the small nucleolar non-coding RNA SNORD9 prevents its interaction with METTL3, downregulates NFYA mRNA expression levels, and, consequently, decreases the expression of its target genes (CCND1, CDK4, and VEGFA), suppressing ovarian cancer progression [100].